Mabion S.A. (WSE:MAB)
Poland · Delayed Price · Currency is PLN 8.00
+0.11 (1.39%)
Jan 7, 2026, 5:00 PM CET
Mabion Market Cap
Mabion has a market cap or net worth of 127.52 million as of January 7, 2026. Its market cap has decreased by -22.95% in one year.
Market Cap
127.52M
Enterprise Value
125.83M
Revenue
14.81M
Ranking
n/a
PE Ratio
n/a
Stock Price
8.00
Market Cap Chart
Since August 10, 2010, Mabion's market cap has increased from 93.01M to 127.52M, an increase of 37.10%. That is a compound annual growth rate of 2.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 5, 2026 | 127.52M | 13.04% |
| Dec 30, 2025 | 112.81M | -21.57% |
| Dec 30, 2024 | 143.84M | -50.96% |
| Dec 29, 2023 | 293.35M | -13.57% |
| Dec 30, 2022 | 339.41M | -65.63% |
| Dec 30, 2021 | 987.46M | 246.59% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Diagnostyka | 5.84B |
| NEUCA | 3.70B |
| Synektik Spólka Akcyjna | 2.44B |
| Voxel | 1.35B |
| Celon Pharma | 1.12B |
| Selvita | 805.81M |
| Ryvu Therapeutics | 635.80M |
| Centrum Medyczne ENEL-MED | 509.05M |